Nevirapine-selected mutations Y181I/C of HIV-1 reverse transcriptase confer cross-resistance to stavudine

被引：18
|
作者：
Baldanti, F [1 ]
Paolucci, S
Maga, G
Labo, N
Hübscher, U
Skoblov, AY
Victorova, L
Spadari, S
Minoli, L
Gerna, G
机构：
[1] IRCCS, Policlin San Matteo, Serv Virol, Pavia, Italy
[2] CNR, Ist Genet Mol, Pavia, Italy
[3] Univ Zurich, Inst Vet Biochem & Mol Biol, Zurich, Switzerland
[4] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia
[5] Univ Pavia, Ist Clin Malattie Infett, Pavia, Italy
来源：
AIDS | 2003年 / 17卷 / 10期
关键词：
D O I：
10.1097/00002030-200307040-00021
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Stavudine administration did not increase the frequency of Y181I/C reverse transcriptase (RT) mutations in non-nucleoside reverse transcriptase inhibitor (NNRTI)-treated patients. However, recombinant Y181C HIV-1 showed reduced stavudine susceptibility with respect to both recombinant wild-type and K103N HIV-1 strains. In addition, recombinant Y181I RT enzyme showed reduced susceptibility to stavudine with respect to both wild-type and K103N RT. A previously unnoticed role of Y181I/C RT changes selected by nevirapine or other NNRTI in determining stavudine resistance is documented.
引用
收藏
页码：1568 / 1570
页数：3
相关论文
共 50 条
  • [31] Mutations in the C-terminal region of the HIV-1 reverse transcriptase and their correlation with drug resistance associated mutations and antiviral treatment
    I Michels
    S Staszewski
    L Gürtler
    G Nisius
    A Müller
    L Locher
    H-W Doerr
    M Stürmer
    European Journal of Medical Research, 15
  • [32] Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen
    Delaugerre, C
    Rohban, R
    Simon, A
    Mouroux, M
    Tricot, C
    Agher, R
    Huraux, JM
    Katlama, C
    Calvez, V
    JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (03) : 445 - 448
  • [33] Exploiting HIV-1 protease and reverse transcriptase cross-resistance information for improved drug resistance prediction by means of multi-label classification
    Riemenschneider, Mona
    Senge, Robin
    Neumann, Ursula
    Huellermeier, Eyke
    Heider, Dominik
    BIODATA MINING, 2016, 9
  • [34] Exploiting HIV-1 protease and reverse transcriptase cross-resistance information for improved drug resistance prediction by means of multi-label classification
    Mona Riemenschneider
    Robin Senge
    Ursula Neumann
    Eyke Hüllermeier
    Dominik Heider
    BioData Mining, 9
  • [35] Should we include connection domain mutations of HIV-1 reverse transcriptase in HIV resistance testing?
    Gotte, Matthias
    PLOS MEDICINE, 2007, 4 (12) : 1858 - 1861
  • [36] Phenotypic drug resistance patterns in subtype a HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations
    Eshleman, SH
    Jones, D
    Galovich, J
    Paxinos, EE
    Petropoulos, CJ
    Jackson, JB
    Parkin, N
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (03) : 289 - 293
  • [37] The N348I Mutation at the Connection Subdomain of HIV-1 Reverse Transcriptase Decreases Binding to Nevirapine
    Schuckmann, Matthew M.
    Marchand, Bruno
    Hachiya, Atsuko
    Kodama, Eiichi N.
    Kirby, Karen A.
    Singh, Kamalendra
    Sarafianos, Stefan G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (49) : 38700 - 38709
  • [38] The Base Component of 3′-Azido-2′,3′-Dideoxynucleosides Influences Resistance Mutations Selected in HIV-1 Reverse Transcriptase
    Meteer, Jeffrey D.
    Koontz, Dianna
    Asif, Ghazia
    Zhang, Hong-wang
    Detorio, Mervi
    Solomon, Sarah
    Coats, Steven J.
    Sluis-Cremer, Nicolas
    Schinazi, Raymond F.
    Mellors, John W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (08) : 3758 - 3764
  • [39] Impact of the N348I Mutation in HIV-1 Reverse Transcriptase on Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Non-Subtype B HIV-1
    McCormick, Adele L.
    Parry, Chris M.
    Crombe, Anne
    Goodall, Ruth L.
    Gupta, Ravindra K.
    Kaleebu, Pontiano
    Kityo, Cissy
    Chirara, Michael
    Towers, Greg J.
    Pillay, Deenan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (04) : 1806 - 1809
  • [40] Altered Viral Fitness and Drug Susceptibility in HIV-1 Carrying Mutations That Confer Resistance to Nonnucleoside Reverse Transcriptase and Integrase Strand Transfer Inhibitors
    Hu, Zixin
    Kuritzkes, Daniel R.
    JOURNAL OF VIROLOGY, 2014, 88 (16) : 9268 - 9276
12345